Millie
your market intelligence analyst
Search Results
676 results
Your search is now limited to «Prostate Cancer» expert search.
Hi gaz67 ,7 weeks after r p just seen consultant all looks good to him brilliant. My I continence is not so good ,I use no 4 pad 5 a day sometimes more ,they also prescribe tadalafil to help with my shrinkage.as you say we are all different cheers scotty.
More from Macmillan Cancer - Prostate Forum:
Lifeboat News: The Blog 08/23/2019 10:23
Sperm DNA experiment could end breast, ovarian and prostate cancer.
More from Lifeboat News: The Blog:
Molecules containing lysine‐ureido‐glutamic acid functional groups bind to the active site of prostate specific membrane antigen which is overexpressed in prostate cancer.
More from Angewandte Chemie International Edition:
Gene editing experiment in sperm could end breast, ovarian and prostate cancer.
More from Mail on Sunday (United Kingdom):
PubMed News (NIH) 08/23/2019
Series Type : Expression profiling by high throughput sequencing ; Genome binding/occupancy profiling by high throughput sequencing Organism : Homo sapiens. This SuperSeries is composed of the SubSeries listed below.
More from PubMed News (NIH):
Healio News 08/22/2019 11:31
The complementary data from the ARCHES and ENZAMET trials in men with [metastatic hormone-sensitive prostate cancer] take us another step closer to understanding Xtandi’s full potential in helping address unmet needs in prostate cancer,” Andrew Krivoshik, MD, PhD, senior vice president and oncology therapeutic area head at Astellas Pharma, said in ...
More from Healio News:
FDA review finds no increased risk of prostate cancer with Parkinson's disease medicines containing entacapone (Comtan, Stalevo.
More from U.S. Food & Drug Administration - FDA - What's New: Drugs (FDA):
PR Newswire 08/22/2019 09:05
Recognizing Prostate and Ovarian Cancer Awareness Month this September, specialty lender Fifth Season Financial has developed a solution to help alleviate the financial strain associated with these cancers as well as other advanced-stage illnesses.
More from PR Newswire:
PharmaTimes 08/22/2019 06:05
In men with prostate cancer, the disease is considered metastatic once the cancer has spread outside of the prostate gland to other parts of the body, such as the bones, lymph nodes, bladder and rectum, with approximately 38,000 men ...
More from PharmaTimes:
However, few studies have investigated the relationship between COPD and prostate cancer (PCa.
More from International Journal of COPD:
Onclive 08/21/2019 15:51
The FDA has granted a priority review designation to a supplemental new drug application for enzalutamide (Xtandi) for the treatment of men with metastatic hormone-sensitive prostate cancer (mHSPC), according to Astellas Pharma Inc. and Pfizer Inc., the codevelopers of the androgen receptor inhibitor.
More from Onclive:
Targeted Oncology 08/21/2019 15:11
The FDA has granted a priority review to a supplemental New Drug Application (sNDA) for a new indication for enzalutamide (Xtandi) as a treatment for men with metastatic hormone-sensitive prostate cancer (mHSPC.
More from Targeted Oncology:
Business Wire 08/21/2019 14:00
The submission is supported by a strong data package, including two Phase 3 trials investigating XTANDI in men living with this form of prostate cancer.
More from Business Wire:
Prostate Cancer INFOLINK 08/21/2019 09:40
As far as The “New” Prostate Cancer InfoLink is concerned, however, it has yet to be demonstrated that this technique can be used safely and effectively for the treatment of prostate cancer.
More from Prostate Cancer INFOLINK:
ClinicalTrials.gov 08/21/2019 08:04
This feasibility study will assess the acceptability of an MRI as a prostate cancer screening assessment and assess the prevalence of MRI defined suspicious lesions and cancer in men across a spectrum of PSA results.
More from ClinicalTrials.gov:
News-Medical.net 08/21/2019 04:01
FDA clears its IND for new immunotherapeutic for treating prostate cancer.
More from News-Medical.net:
Improved Imaging Technique Could Increase Chances of Prostate Cancer Survival.
More from Imaging Technology News:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications